Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson’s Disease

被引:0
作者
Jyothi K. Mallajosyula
Shankar J. Chinta
Subramanian Rajagopalan
David G. Nicholls
Julie K. Andersen
机构
[1] Buck Institute for Age Research,
来源
Neurotoxicity Research | 2009年 / 16卷
关键词
Mitochondrial dysfunction; Monoamine oxidase B; Hydrogen peroxide; Krebs cycle enzymes; Metabolic control analysis; Reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
We previously demonstrated that spare respiratory capacity of the TCA cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) was completely abolished upon increasing levels of MAO-B activity in a dopaminergic cell model system (Kumar et al., J Biol Chem 278:46432–46439, 2003). MAO-B mediated increases in H2O2 also appeared to result in direct oxidative inhibition of both mitochondrial complex I and aconitase. In order to elucidate the contribution that each of these components exerts over metabolic respiratory control as well as the impact of MAO-B elevation on their spare respiratory capacities, we performed metabolic respiratory control analysis. In addition to KGDH, we assessed the activities and substrate-mediated respiration of complex I, pyruvate dehydrogenase (PDH), succinate dehydrogenase (SDH), and mitochondrial aconitase in the absence and presence of complex-specific inhibitors in specific and mixed substrate conditions in mitochondria from our MAO-B elevated cells versus controls. Data from this study indicates that Complex I and KGDH are the most sensitive to inhibition by MAO-B mediated H2O2 generation, and could be instrumental in determining the fate of mitochondrial metabolism in this cellular PD model system.
引用
收藏
页码:186 / 193
页数:7
相关论文
共 50 条
  • [21] Rutin as promising drug for the treatment of Parkinson's disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies
    Azam, Faizul
    Abodabos, Honiwa Suliman
    Taban, Ismail M.
    Rfieda, Abdalla R.
    Mahmood, Danish
    Anward, Jamir
    Khan, Shamshir
    Sizochenko, Natalia
    Poli, Giulio
    Tuccinardi, Tiziano
    Ali, Hamed, I
    MOLECULAR SIMULATION, 2019, 45 (18) : 1563 - 1571
  • [22] In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson's Disease
    Kondeva-Burdina, Magdalena
    Mateev, Emilio
    Angelov, Borislav
    Tzankova, Virginia
    Georgieva, Maya
    MOLECULES, 2022, 27 (23):
  • [23] Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism
    Costa-Mallen, P
    Costa, LG
    Smith-Weller, T
    Franklin, GM
    Swanson, PD
    Checkoway, H
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (04) : 535 - 537
  • [24] Suffruticosol B from Paeonia lactiflora Ameliorates Alzheimer's Disease Pathology by Inhibiting MAO-B Activity
    Heo, Jae-Jun
    Han, Young-Eun
    Kim, Min Soo
    Cheong, Eunji
    Choi, Chun Whan
    Oh, Soo-Jin
    PHYTOTHERAPY RESEARCH, 2025, 39 (02) : 593 - 603
  • [25] Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease
    Azam, Faizul
    Madil, Arwa M.
    Ali, Hamed I.
    JOURNAL OF YOUNG PHARMACISTS, 2012, 4 (03) : 184 - 192
  • [26] Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
    Jaisa-aad, Methasit
    Munoz-Castro, Clara
    Healey, Molly A.
    Hyman, Bradley T.
    Serrano-Pozo, Alberto
    ACTA NEUROPATHOLOGICA, 2024, 147 (01)
  • [27] Network-Based Drug Optimization toward the Treatment of Parkinson's Disease: NRF2, MAO-B, Oxidative Stress, and Chronic Neuroinflammation
    Duarte, Pablo
    Sanchez-Porro, Francisco J.
    Crisman, Enrique
    Cores, Angel
    Jimenez, Irene
    Cuadrado, Antonio
    Menendez, J. Carlos
    Leon, Rafael
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 3495 - 3517
  • [28] Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer’s disease and related dementias
    Methasit Jaisa-aad
    Clara Muñoz-Castro
    Molly A. Healey
    Bradley T. Hyman
    Alberto Serrano-Pozo
    Acta Neuropathologica, 2024, 147
  • [29] Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein-Inhibitor Complexes in Relevance to Developing Parkinson's Therapeutics
    Murugan, Natarajan Arul
    Muvva, Charuvaka
    Jeyarajpandian, Chitra
    Jeyakanthan, Jeyaraman
    Subramanian, Venkatesan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 15
  • [30] Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression
    Siddiqui, Almas
    Mallajosyula, Jyothi K.
    Rane, Anand
    Andersen, Julie K.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (02) : 444 - 448